Edition:
United States

Agios Pharmaceuticals Inc (AGIO.O)

AGIO.O on Nasdaq

49.71USD
28 Apr 2017
Change (% chg)

$-1.20 (-2.36%)
Prev Close
$50.91
Open
$50.85
Day's High
$51.33
Day's Low
$49.60
Volume
762,564
Avg. Vol
684,024
52-wk High
$67.74
52-wk Low
$35.84

Select another date:

Fri, Apr 28 2017

BRIEF-Agios announces closing of over-allotment option in public offering

* Agios announces closing of over-allotment option in public offering

BRIEF-Agios and Aurigene enter into license agreement for novel small molecules for cancer metabolism target

* Agios and aurigene enter into exclusive license agreement for novel small molecules for cancer metabolism target

BRIEF-Agios Pharmaceuticals announces MTAP pathway research program and collaboration agreement with Celgene

* Agios announces MTAP pathway research program as development program and development candidate under master research and collaboration agreement with Celgene

BRIEF-Agios says cash, marketable securities were $573.6 mln as of Dec. 31

* Agios reports fourth quarter and full year 2016 financial results and highlights key 2017 milestones

BRIEF-Agios pharmaceuticals AG-120 NDA submission for IDH1M R/R AML planned by year end 2017

* AG-120 NDA submission for IDH1M R/R AML planned by year end 2017

BRIEF-Agios provides early-stage data on AG-120 in glioma, chondrosarcoma patients

* Agios announces phase 1 data from dose expansion cohorts of AG-120 in patients with IDH1 mutant positive glioma and chondrosarcoma Source text for Eikon: Further company coverage:

BRIEF-Agios posts Q3 shr loss $1.63

* Agios Pharmaceuticals inc - now expects to end 2016 with more than $550 million of cash, cash equivalents and marketable securities

Select another date:

More From Around the Web